Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Everolimus.

Hasskarl J.

Recent Results Cancer Res. 2014;201:373-92. doi: 10.1007/978-3-642-54490-3_23. Review.

PMID:
24756805
2.

Sorafenib: targeting multiple tyrosine kinases in cancer.

Hasskarl J.

Recent Results Cancer Res. 2014;201:145-64. doi: 10.1007/978-3-642-54490-3_8. Review.

PMID:
24756790
3.

Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.

Harder J, Müller MJ, Fuchs M, Gumpp V, Schmitt-Graeff A, Fischer R, Frank M, Opitz O, Hasskarl J.

World J Gastroenterol. 2013 Dec 28;19(48):9334-42. doi: 10.3748/wjg.v19.i48.9334.

4.

ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes.

May AM, Frey AV, Bogatyreva L, Benkisser-Petersen M, Hauschke D, Lübbert M, Wäsch R, Werner M, Hasskarl J, Lassmann S.

Histochem Cell Biol. 2014 Apr;141(4):431-40. doi: 10.1007/s00418-013-1169-7. Epub 2013 Nov 30.

PMID:
24292846
5.

Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study.

Dietrich H, Hu K, Ruffin M, Song D, Bouillaud E, Wang Y, Hasskarl J.

Eur J Endocrinol. 2012 May;166(5):821-8. doi: 10.1530/EJE-11-0773. Epub 2012 Mar 1.

6.

Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.

Hasskarl J, Kaufmann M, Schmid HA.

Future Oncol. 2011 Jul;7(7):895-913. doi: 10.2217/fon.11.66. Review.

PMID:
21732759
7.

Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft.

Hasskarl J, Zerweck A, Wäsch R, Ihorst G, Bertz H, Finke J.

Bone Marrow Transplant. 2012 Feb;47(2):277-82. doi: 10.1038/bmt.2011.45. Epub 2011 Apr 4.

PMID:
21460873
8.

Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma.

Hasskarl J, Ihorst G, De Pasquale D, Schröttner P, Zerweck A, Wäsch R, Engelhardt M.

Leuk Lymphoma. 2011 Feb;52(2):247-59. doi: 10.3109/10428194.2010.529207. Epub 2010 Nov 5.

PMID:
21054148
9.

Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.

Mern DS, Hasskarl J, Burwinkel B.

Br J Cancer. 2010 Oct 12;103(8):1237-44. doi: 10.1038/sj.bjc.6605897. Epub 2010 Sep 14.

10.

Achievement of a continuous complete remission in a kidney transplant patient with advanced donor-derived small cell carcinoma.

Schroettner P, Gruellich C, Hasskarl J, Waller CF.

Transplantation. 2010 Jul 15;90(1):94-5. doi: 10.1097/TP.0b013e3181d9e1ac. No abstract available.

PMID:
20606565
11.

Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.

Mern DS, Hoppe-Seyler K, Hoppe-Seyler F, Hasskarl J, Burwinkel B.

Breast Cancer Res Treat. 2010 Dec;124(3):623-33. doi: 10.1007/s10549-010-0810-6. Epub 2010 Feb 27.

PMID:
20191379
12.

BI_2536--targeting the mitotic kinase Polo-like kinase 1 (Plk1).

Wäsch R, Hasskarl J, Schnerch D, Lübbert M.

Recent Results Cancer Res. 2010;184:215-8. doi: 10.1007/978-3-642-01222-8_15. Review.

PMID:
20072841
13.

Sorafenib.

Hasskarl J.

Recent Results Cancer Res. 2010;184:61-70. doi: 10.1007/978-3-642-01222-8_5. Review.

PMID:
20072831
14.

Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.

Manthey C, Mern DS, Gutmann A, Zielinski AJ, Herz C, Lassmann S, Hasskarl J.

BMC Cell Biol. 2010 Jan 14;11:2. doi: 10.1186/1471-2121-11-2.

15.

Successful treatment of severe acute intestinal graft-versus-host resistant to systemic and topical steroids with alemtuzumab.

Schnitzler M, Hasskarl J, Egger M, Bertz H, Finke J.

Biol Blood Marrow Transplant. 2009 Aug;15(8):910-8. doi: 10.1016/j.bbmt.2009.04.002. Erratum in: Biol Blood Marrow Transplant. 2010 Jan;16(1):128.

16.

Severe Organizing Pneumonia after Two Cycles of Docetaxel as Fourth-Line Chemotherapy for Advanced Non-Small Cell Carcinoma of the Lung.

Hasskarl J, Schroettner P, von den Berg A, Rueckert A, Frydrychowicz A, Kayser G, Waller CF.

Case Rep Oncol. 2009 Feb 16;2(1):12-19.

17.

Complete caval thrombosis secondary to an implanted venous port--a case study.

Hasskarl J, Köberich S, Frydrychowicz A, Illerhaus G, Waller CF.

Dtsch Arztebl Int. 2008 Jan;105(1-2):18-21. doi: 10.3238/arztebl.2008.0018. Epub 2008 Jan 7.

18.

Interference of the dominant negative helix-loop-helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities.

Hasskarl J, Mern DS, Münger K.

Oncogene. 2008 Mar 13;27(12):1657-64. Epub 2007 Sep 24.

PMID:
17891176
19.

[Origin and role of aneuploidy in cancer].

Schnerch D, Hasskarl J, Engelhardt M, Wäsch R.

Dtsch Med Wochenschr. 2006 Aug 4;131(31-32):1747-53. German.

PMID:
16868879
20.

Increased in vitro lifespan of primary human keratinocytes correlates with decreased migration.

Hasskarl J, Velupillai P, Münger K.

J Invest Dermatol. 2006 May;126(5):1179-81. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk